Astellas opens new headquarters in Illinois, creates 150 jobs

Tuesday, June 5, 2012 08:01 AM

Astellas Pharma U.S., subsidiary of Tokyo-based Astellas Pharma, has opened its new headquarters in Glenview, Ill., serving the Americas.

The new headquarters includes two seven-story buildings totaling 446,000 square feet, an increase of more than 160,000 square feet, which makes it more than a third larger than the former Deerfield, Ill., location. The buildings and site emphasize sustainability, and the complex is designed to achieve LEED Gold certification. The company’s more than 1,000 employees recently relocated to the new headquarters, and the expansion includes the addition of 150 good paying, high-tech jobs.

Along with the expansion, Astellas will be investing $140 million in Illinois, creating 150 new high-tech jobs.

“At Astellas, we measure success not only by bringing innovative pharmaceuticals to patients and physicians, but also by our commitment to the communities in which we work,” said Masao Yoshida, president and CEO of Astellas Pharma US. “The new Astellas headquarters for the Americas is a symbol of the company’s continued growth, and our close cooperation with the state of Illinois and Governor Quinn’s office. The new buildings are a result of that collaboration and our confidence that Illinois is a good place to do business.”

To bolster the company's $140 million investment in Illinois, the Department of Commerce and Economic Opportunity (DCEO) is providing a strategic investment package of approximately $4 million in Economic Development for a Growing Economy (EDGE) corporate income tax credits and Employer Training Investment Program (ETIP) job training funds. ETIP credits will help Astellas enhance the skills of its workforce while EDGE credits are based and contingent on job creation. If the company does not meet its job creation targets and commitments, they will no longer be eligible for the tax credits.

“We are committed to establishing Illinois as a leading hub of life sciences, and our work is paying off,” said Illinois governor Pat Quinn. “Illinois has some of the best research and intellectual capital in the world, and these assets help us attract and support the growth of high-potential companies like Astellas in Illinois.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs